Literature DB >> 24080522

Synthesis of methoxy-X04 derivatives and their evaluation in Alzheimer's disease pathology.

Alexander Boländer1, Daniel Kieser, Christoph Scholz, Roland Heyny-von Haußen, Gerhard Mall, Valérie Goetschy, Christian Czech, Boris Schmidt.   

Abstract

BACKGROUND: Alzheimer's disease is characterized by two notorious protein aggregates in the brain: extracellular senile plaques mainly consisting of amyloid-β peptides and tau-protein-derived intracellular paired helical filaments. The diagnosis of Alzheimer's disease is impaired by insufficient sensitivity and specificity of diagnostic methods to visualize these pathological hallmarks over all disease stages.
OBJECTIVE: The established fluorescence marker methoxy-X04 stains plaques, tau tangles and amyloid-derived angiopathies with good specificity, yet it is limited by slow elimination in vivo. Since the need for new markers is high, we prepared methoxy-X04 derivatives and evaluated their potential as imaging agents in Alzheimer's disease pathology. METHODS AND
RESULTS: In this study, we describe an improved synthesis for methoxy-X04 and its derivatives and their affinity determination for the respective protein targets by immunohistology and a displacement assay.
CONCLUSION: This resulted in the identification of new derivatives of methoxy-X04 with improved binding affinity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24080522     DOI: 10.1159/000351436

Source DB:  PubMed          Journal:  Neurodegener Dis        ISSN: 1660-2854            Impact factor:   2.977


  4 in total

1.  Evaluation of the methoxy-X04 derivative BSC4090 for diagnosis of prodromal and early Alzheimer's disease from bioptic olfactory mucosa.

Authors:  Hannah Pellkofer; Friedrich Ihler; Bernhard G Weiss; Janina Trothe; Harindranath Kadavath; Monika Chongtham; Marcel Kunadt; Dietmar Riedel; Finn Lornsen; Petra Wilken; Claudia Bartels; Sina Hirschel; Sebastian G Russo; Elke Stransky; Lutz Trojan; Boris Schmidt; Eckhardt Mandelkow; Markus Zweckstetter; Martin Canis; Anja Schneider
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-11-12       Impact factor: 5.270

2.  Retromer regulates the lysosomal clearance of MAPT/tau.

Authors:  Julian M Carosi; Leanne K Hein; Mark van den Hurk; Robert Adams; Bridget Milky; Sanjna Singh; Cedric Bardy; Donna Denton; Sharad Kumar; Timothy J Sargeant
Journal:  Autophagy       Date:  2020-09-22       Impact factor: 16.016

3.  Amphiphilic Distyrylbenzene Derivatives as Potential Therapeutic and Imaging Agents for Soluble and Insoluble Amyloid β Aggregates in Alzheimer's Disease.

Authors:  Liang Sun; Hong-Jun Cho; Soumyo Sen; Andres S Arango; Truc T Huynh; Yiran Huang; Nilantha Bandara; Buck E Rogers; Emad Tajkhorshid; Liviu M Mirica
Journal:  J Am Chem Soc       Date:  2021-07-02       Impact factor: 15.419

4.  Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer disease.

Authors:  Nicole Schröder; Anja Schaffrath; Josua A Welter; Tim Putzka; Angelika Griep; Patrick Ziegler; Elisa Brandt; Sebastian Samer; Michael T Heneka; Hannes Kaddatz; Jiangshan Zhan; Eugenia Kipp; Thomas Pufe; Simone C Tauber; Markus Kipp; Lars-Ove Brandenburg
Journal:  J Neuroinflammation       Date:  2020-04-24       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.